List of insiders holdings for CervoMed Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Feller Paul Chief Executive Officer 10% Owner | 2010-04-15 13:22:23 | 28,399,768 0 | 28,399,768 | Form 4 |
| 2 | Gilliam Richard Baxter 10% Owner | 2016-02-19 13:41:37 | 12,687,975 0 | 12,687,975 | Form 3 |
| 3 | Feller Ralph 10% Owner | 2008-03-31 14:18:04 | 9,329,655 0 | 9,329,655 | Form 3 |
| 4 | BLECH ISAAC Liberty Charitable Remainder Trust f/b/o Isaac Blech West Charitable Remainder Unitrust Blech Miriam 10% Owner | 2014-12-12 16:31:48 | 1,976,145 0 | 1,976,145 | Form 13D |
| 5 | BLECH ISAAC Liberty Charitable Remainder Trust f/b/o Isaac Blech River Charitable Remainder Unitrust f/b/o Isaac Blech West Charitable Remainder Unitrust 10% Owner | 2014-12-12 16:31:48 | 1,976,145 0 | 1,976,145 | Form 13D |
| 6 | Jones David Randolph Chief Medical Officer | 2016-01-15 16:24:17 | 1,734,039 0 | 1,734,039 | Form 3 |
| 7 | SHERRIS DAVID Chief Scientific Officer | 2014-12-12 16:31:17 | 1,646,302 0 | 1,646,302 | Form 13D |
| 8 | ALAM JOHN J CEO & President 10% Owner | 2025-11-19 07:45:08 | 1,484,078 12,500 | 1,496,578 | Form 4 |
| 9 | Gregoire Sylvie Director 10% Owner | 2025-11-19 07:45:56 | 1,484,078 12,500 | 1,496,578 | Form 4 |
| 10 | BARER SOL J Director | 2014-12-12 16:31:05 | 1,398,371 0 | 1,398,371 | Form 13D |
| 11 | Schneider John Director | 2012-09-14 11:44:30 | 1,079,105 0 | 1,079,105 | Form 3 |
| 12 | RUBINSTEIN JEROLD H Director | 2011-06-03 18:58:45 | 900,000 0 | 900,000 | Form 3 |
| 13 | GOLENBERG GLENN Director | 2009-05-14 18:27:39 | 628,000 0 | 628,000 | Form 3 |
| 14 | SIMES STEPHEN M Chief Executive Officer | 2014-07-29 10:50:51 | 542,975 0 | 542,975 | Form 4 |
| 15 | Weinberg Mark A. Sr. V.P.- Clinical Development | 2014-08-06 13:05:15 | 521,475 0 | 521,475 | Form 4 |
| 16 | Dunleavy Mike Sr. Director | 2009-11-05 14:57:51 | 455,000 0 | 455,000 | Form 3 |
| 17 | Cross Randall Director | 2009-05-26 21:50:28 | 450,000 0 | 450,000 | Form 3 |
| 18 | SIEGEL SEYMOUR Director | 2012-09-05 19:53:15 | 450,000 0 | 450,000 | Form 3 |
| 19 | Hornung William Karl Chief Financial Officer | 2022-01-31 06:08:56 | 305,743 0 | 305,743 | Form 4 |
| 20 | GALLOWAY CHRISTOPHER D Chief Medical Officer | 2022-01-31 06:06:09 | 305,743 0 | 305,743 | Form 4 |
| 21 | DONENBERG PHILIP B Director | 2014-07-29 10:47:13 | 271,475 0 | 271,475 | Form 4 |
| 22 | Kalergis David G Chairman and CEO | 2020-01-30 16:54:56 | 262,900 0 | 262,900 | Form 4 |
| 23 | Gainer John Chief Scientific Officer | 2020-01-30 16:55:48 | 239,400 0 | 239,400 | Form 4 |
| 24 | BLECH ISAAC Director | 2016-09-16 16:05:21 | 204,907 0 | 204,907 | Form 4 |
| 25 | Schwartz Yael Exe. VP Preclinical Dev. | 2014-07-29 10:48:36 | 119,482 0 | 119,482 | Form 4 |
| 26 | Giles Mark T Director | 2021-07-06 21:41:18 | 83,300 0 | 83,300 | Form 4 |
| 27 | Adams Robert W Director | 2021-07-06 21:41:56 | 83,300 0 | 83,300 | Form 4 |
| 28 | LEVIN ALAN G Director | 2021-07-06 21:42:16 | 83,300 0 | 83,300 | Form 4 |
| 29 | Boris Timothy Director | 2014-07-29 10:46:18 | 79,655 0 | 79,655 | Form 4 |
| 30 | STACKS NELSON K. Director | 2014-07-29 10:51:21 | 61,374 0 | 61,374 | Form 4 |
| 31 | Bright Rex Director | 2014-07-29 10:46:46 | 61,085 0 | 61,085 | Form 4 |
| 32 | De Rosch Mark EVP, RA and GA and PgM | 2025-05-23 16:12:37 | 59,000 0 | 59,000 | Form 3 |
| 33 | Abolin Craig VP of Research & Dev - Subsid. | 2014-06-12 12:45:16 | 57,596 0 | 57,596 | Form 4 |
| 34 | RUFFOLO ROBERT R Director | 2018-06-18 16:36:52 | 40,000 0 | 40,000 | Form 4 |
| 35 | Cobuzzi Robert Joseph Jr. Chief Operating Officer | 2025-02-14 18:01:32 | 27,000 0 | 27,000 | Form 4 |
| 36 | Blackburn Kelly SVP, Clinical Development | 2025-02-14 18:00:53 | 27,000 0 | 27,000 | Form 4 |
| 37 | Byrne Thomas E General Counsel | 2020-01-09 17:03:50 | 25,000 0 | 25,000 | Form 4 |
| 38 | Shealy Ben Sr VP Finance & Treasurer | 2018-01-04 16:03:24 | 25,000 0 | 25,000 | Form 4 |
| 39 | Quigley David Director | 2025-12-05 18:16:27 | 16,200 0 | 16,200 | Form 4 |
| 40 | TANNER JOHN WILLIAM Chief Financial Officer | 2024-01-26 18:46:09 | 16,000 0 | 16,000 | Form 4 |
| 41 | Winton Matthew Chief Commercial and Business | 2025-11-19 07:46:15 | 15,000 0 | 15,000 | Form 4 |
| 42 | ELDER WILLIAM ROBERT CFO, GC & Secretary | 2025-11-19 07:45:32 | 12,500 0 | 12,500 | Form 4 |
| 43 | Hollingsworth Jane H Director | 2025-06-25 17:01:02 | 8,100 0 | 8,100 | Form 4 |
| 44 | Poulton Jeffrey V. Director | 2025-06-25 17:01:55 | 8,100 0 | 8,100 | Form 4 |
| 45 | Sabbagh Marwan Director | 2025-06-25 17:02:45 | 8,100 0 | 8,100 | Form 4 |
| 46 | BOGER JOSHUA S Director 10% Owner | 2025-06-25 17:03:28 | 8,100 0 | 8,100 | Form 4 |
| 47 | ZAVRL FRANK Director | 2025-06-25 17:04:25 | 8,100 0 | 8,100 | Form 4 |
| 48 | JAEGER RAVEN Chief Regulatory Officer | 2022-08-26 18:08:07 | 8,000 0 | 8,000 | Form 4 |
| 49 | DAVIDSON JILL Director | 2023-09-15 18:50:32 | 6,450 0 | 6,450 | Form 4 |
| 50 | LANCHONEY DIANA M Director | 2023-07-05 17:30:37 | 1,222 0 | 1,222 | Form 4 |
| 51 | Francois Eric Director | 2021-10-15 20:00:34 | 0 0 | 0 | Form 3 |
| 52 | BEARCHELL CHARLES R Chief Accounting Officer | 2011-09-20 13:52:23 | 0 0 | 0 | Form 3 |